International Study of Cerebral Oxygenation and Electrical Activity During Major Neonatal Surgery
Launched by CHILDREN'S HOSPITAL OF PHILADELPHIA · Dec 21, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying brain oxygen levels and electrical activity in newborns who are undergoing major surgery for birth defects. The researchers want to find out how often babies experience a drop in brain oxygen levels during surgery and what factors might contribute to this. They will also look at how these changes in brain oxygen relate to the babies' overall health and recovery after surgery.
To participate in this study, infants must be 60 weeks or younger in terms of their development and scheduled for surgery related to specific congenital conditions, such as issues with the intestines or lungs. Parents or guardians will need to give permission for their child to join. During the trial, babies will be monitored using special equipment to measure brain activity and oxygen levels for about an hour before surgery, throughout the surgery, and for up to 24 hours afterward. This research aims to improve understanding and care for newborns undergoing these important procedures.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Infants ≤ 60 weeks post-menstrual age on day of surgery.
- • 2. Neonatal surgery for congenital abdominal/gastrointestinal malformations (diaphragmatic hernia, gastroschisis, omphalocele, intestinal atresia, Hirschsprung's disease, imperforate anus, necrotizing enterocolitis), congenital cystic adenomatoid/pulmonary airway malformation (CCAM/CPAM), esophageal/tracheoesophageal fistula (EF/TEF), and spinal malformations (myelomeningocele, sacrococcygeal teratoma).
- • 3. The same patient may be enrolled multiple times for repeat or different procedures that meet the above criteria. These subjects will be counted more than once towards the enrollment goal.
- • 4. Parental/guardian permission.
- Exclusion Criteria:
- • 1) Patients with hydrocephalus limiting frontal-parietal brain volume, interventricular hemorrhage (grades 3 or 4), malformation or cerebral infarction of frontal-parietal brain.
About Children's Hospital Of Philadelphia
The Children's Hospital of Philadelphia (CHOP) is a leading pediatric healthcare institution renowned for its commitment to advancing child health through innovative research and clinical care. As a prominent clinical trial sponsor, CHOP emphasizes a multidisciplinary approach to pediatric research, fostering collaborations across various specialties to develop and evaluate groundbreaking therapies and interventions. With a focus on improving patient outcomes and enhancing the quality of life for children, CHOP is dedicated to conducting rigorous clinical trials that adhere to the highest ethical standards and scientific integrity, ultimately contributing to the global knowledge base in pediatric medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
Dallas, Texas, United States
Houston, Texas, United States
Vellore, , India
New York, New York, United States
Chandigarh, , India
London, , United Kingdom
Parkville, , Australia
Shenyang, , China
Shanghai, , China
Guangzhou, , China
Nedlands, , Australia
São Paulo, , Brazil
Sichuan, , China
Bordeaux, , France
New York, New York, United States
Patients applied
Trial Officials
Ian Yuan, MD
Principal Investigator
Children's Hospital of Philadelphia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials